A Review of Metabolic Disorder of Amino Acid Tyrosinemia type I: When to Suspect and how to Diagnose

Journal Title: IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) - Year 2017, Vol 12, Issue 2

Abstract

Background: Hereditary Tyrosinemia I (HT1) is an inborn error of tyrosine catabolism; an autosomal recessive disorder caused by defective activity of fumarylacetoacetate hydrolase (FAH) enzyme, is characterized by progressive liver disease, renal tubular dysfunction, and porphyria-like crises. Succinylacetone (SA); a compound derived from the tyrosine catabolic intermediate fumarylacetoacetate has been demonstrated to be a mitochondrial toxin. Symptoms may start during the first few months (acute type); in second half of the first year (subacute type) or in the following years up to adulthood (chronic type). All patients stand a high risk of developing hepatocellular carcinoma (HCC) secondary to cirrhosis. Diagnostic methods: Elevated levels of SA, α fetoprotein and plasma levels of tyrosine, phenylalanine and methionine, Newborn screening and prenatal diagnosis are available in many countries. Management and treatment: A dramatic improvement in prognosis following treatment with Nitisinone, along with protein-restricted diet and option of liver transplantation in acutely ill infants fails to respond to Nitisinone, or diagnosed HCC. Conclusion: HTI is a treatable disease, it has heterogeneous hepatorenal manifestations. Elevated levels of SA in plasma or urine are diagnostic. An early diagnosis and treatment with Nitisinone is critical to normal development and survival. Individuals should follow a life-long low-tyrosine and phenylalanine diet.

Authors and Affiliations

Hanna Alobaidy1. 2

Keywords

Related Articles

A Prospective Study on Prescription Pattern and Quality Of Life in Epilepsy Patients at a Private Corporate Hospital

A Prospective Study was conducted in Neurology Department on Prescription Pattern and Quality of Life in Epilepsy Patients at a Private Corporate Hospital in Coimbatore, India. A total of 214 cases were found, of which 8...

Development and Validation of an Inductively Coupled Plasma Mass Spectrometry (ICP-MS) Method for the Determination of 17 Trace Metals in Ingenol Mebutate (API)

In this study elemental impurities method of quantitative analysis for the determination of trace metals in Ingenol mebutate (API) by ICP-MS was validated and applied. ICP-MS is a multi-element technique characterized by...

Fecal Tumor M2-Pyruvate Kinase ™ (ScheBo Test) for Colorectal Cancer Detection in Adult Egyptians

Introduction: Colorectal cancer (CRC) represents the 3rd most common tumor worldwide and the 6th in Egypt. It is still burdened by significant morbidity and mortality despite several therapeutic improvements. A gold stan...

EORTC QLQ-OES 18 module strategy for assessment of quality of life in esophageal cancer patients

Esophageal cancer ranks sixth among all cancers in mortality. Advances in medical research have led to improved prognosis and quality of life (QOL) and increased survival rates. The aim of the present study was to evalua...

Biosynthesis of Iron Oxide Nanoparticles using Aqueous Extract of Convolvulus Pluricaulis Plant, its Characterization and Acute Oral Toxicity Studies

The synthesis of nanoparticles by green approach has been of great interest because of its ecofriendly and non-toxic potential in biomedical applications. The present study was aimed to synthesize Convolvulus pluricaulis...

Download PDF file
  • EP ID EP388394
  • DOI 10.9790/3008-1202015664
  • Views 93
  • Downloads 0

How To Cite

Hanna Alobaidy1. 2 (2017). A Review of Metabolic Disorder of Amino Acid Tyrosinemia type I: When to Suspect and how to Diagnose. IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS), 12(2), 56-64. https://europub.co.uk/articles/-A-388394